Join the 200th Anniversary Celebration

Correction

Eculizumab for Atypical Hemolytic–Uremic Syndrome

N Engl J Med 2009; 360:2487June 4, 2009

Article

Eculizumab for Atypical Hemolytic–Uremic Syndrome (Correspondence, N Engl J Med 2009:360;542 - 544) . Thomas Philipp, M.D., should be added as the second author of the letter. We regret the omission. The article has been corrected at NEJM.org.